Blockchain Registration Transaction Record

GeoVax Reports Progress on COVID-19 Vaccine Program and Clinical Trials for Oncology Therapies

GeoVax announces updates on COVID-19 vaccine program, GEO-MVA clinical evaluation, and Gedeptin® Phase 2 trial for head and neck cancer treatment. Learn about the company's innovative immunotherapies and vaccines addressing critical unmet needs in oncology and infectious diseases.

This news matters as GeoVax's advancements in vaccine development and cancer therapies have the potential to impact millions of individuals worldwide. The progress on the COVID-19 vaccine program, GEO-MVA evaluation, and Gedeptin® trial highlights the company's commitment to addressing crucial medical needs, offering hope for improved treatments and preventative measures against infectious diseases and cancer.